Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2-17 years of age.

Bradley JS, Goldman JL, James LP, Kaelin B, Gibson BHY, Arrieta A. Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2-17 years of age. Antimicrob Agents Chemother. 2023 11 15; 67(11):e0098723.

View in: PubMed

collapse authors with profiles